Large-scale testing (Phase 3)Study completedNCT04385368
What this trial is testing
Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)
Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 89